对新生儿阿片类药物戒断综合征复合下方布普伦诺芬溶液的稳定性研究
Arash Ahmadi1, Dina R Cutaia2, Jarred R Perkins2
1School of Pharmacy (AA, DLA), Lake Erie College of Osteopathic Medicine, Erie, PA.
概括
一种新的口服布普伦诺芬配方,不含酒精,糖和防腐剂,在14天内表现出极好的稳定性. 这为新生儿阿片类药物戒断综合征 (NOWS) 提供了潜在的更安全的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 新生儿医学 新生儿医学
- 药物的配方 药物的配方
背景情况:
- 在成年人阿片类药物使用障碍中,口下布伦诺芬是必不可少的.
- 新生儿阿片类药物戒断综合征 (NOWS) 管理显示,布普伦诺芬具有前景.
- 现有的配方不适合新生儿,复合版含有有害的辅助剂.
研究的目的:
- 为了评估一种新型的舌下布诺芬溶液的稳定性.
- 开发一种不含酒精,糖和防腐剂的配方,用于新生儿.
主要方法:
- 使用正常盐水制备了0.075 mg/mL的布普伦诺芬溶液.
- 溶液被储存在珀色的处方瓶和口服注射器中,在冷藏下.
- 质量通过视觉检查,pH和HPLC分析在基线,7日和14天进行评估.
主要成果:
- 在14天内没有观察到视觉或pH值变化.
- 高性能液体色谱证实了>99%的布普伦诺芬度保留.
- 没有检测到任何降解产品,尽管口服注射器中的轻微度增加表明水分流失.
结论:
- 这种新型的口服布普伦诺芬配方是稳定的,并且没有不必要的辅助成分.
- 这种配方可以为NOWS患者提供显著的安全益处.
- 需要进一步的临床研究来确认生物可用性和疗效.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
302
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302
Opioid Analgesics: Morphine and Other Natural Cogeners
253
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
253
One-Compartment Open Model for IV Bolus Administration: General Considerations
210
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
210
Drug Delivery: Enteral Route
460
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
460
Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628


